Insider screener

Period: 12 months Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

22,707 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

22,707 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

22,707 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

22,707 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
22,707 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
22,707 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

22,707 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
3 Feb 2026
Felix George S SVP, Chief Marketing Officer
Sold at will
$1.68M 10,431 at 161.00
56.4%
Sold half or more
3 Feb 2026
VanWees Jason Vice Chairman · indirect
Sold at will 2×
$1.58M 2,500 at 630.46
48.6%
Not planned
3 Feb 2026
Behr Allen C Executive Vice President
Sold at will
$1.43M 7,568 at 188.50
10.1%
Not planned
3 Feb 2026
Biswas Sanjit CHIEF EXECUTVE OFFICER · indirect
Sold on a plan 3×
$1.41M 55,819 at 25.23
45.0%
Planned (10b5-1)
3 Feb 2026
Bicket John SEE REMARKS · indirect
Sold on a plan 4×
$1.40M 55,364 at 25.23
44.8%
Planned (10b5-1)
3 Feb 2026
Roberts Chad EVP, Production Solutions
Sold on a plan
$1.22M 54,706 at 22.39
44.9%
Planned (10b5-1)
3 Feb 2026
BANEY KEVIN D Executive Vice President
Sold at will
$1.22M 9,672 at 126.53
43.4%
Not planned
3 Feb 2026
Fortune Stephen EVP - CD & TO
Sold at will
$1.22M 31,456 at 38.65
27.7%
Not planned
3 Feb 2026
Bloch Laura J Senior Vice President
Sold at will
$1.11M 8,832 at 125.75
59.1%
Sold half or more
3 Feb 2026
Booth Thomas Ryder Chief Technology & Eng Ofr
Sold at will
$1.07M 6,000 at 178.43
92.6%
Sold half or more
3 Feb 2026
Barcelos Elcio R.T. Senior EVP, Chief HR Officer
Sold at will
$1.01M 17,204 at 58.43
16.5%
Not planned
3 Feb 2026
Reynal Vicente See Remarks
Sold on a plan
$913.62K 9,719 at 94.00
4.8%
Planned (10b5-1)
3 Feb 2026
Gallagher Daniel Martin Jr Chief Legal Officer
Sold on a plan 6×
$870.66K 10,000 at 87.07
2.5%
Planned (10b5-1)
3 Feb 2026
Delbos David Portfolio Manager
Bought
$868.00K 100,000 at 8.68
94.8%
First buy on file
3 Feb 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan 2×
$830.28K 3,594 at 231.02
2.0%
Planned (10b5-1)
3 Feb 2026
Guyer William Chief Development Officer
Sold on a plan
$817.33K 20,000 at 40.87
94.2%
Sold half or more
3 Feb 2026
Chulos Nicholas J Chief Legal Officer & Corp Sec · indirect
Sold at will 2×
$751.50K 30,000 at 25.05
59.5%
Sold half or more
3 Feb 2026
Cuffe Michael S. EVP and Chief Clinical Officer
Sold at will
$747.14K 1,500 at 498.09
4.8%
Not planned
3 Feb 2026
Hayne Margaret Co-President & CCO · indirect
Sold on a plan 2×
$675.54K 9,333 at 72.38
0.5%
Planned (10b5-1)
3 Feb 2026
Hunsaker Craig E EVP, PEOPLE & CULTURE
Sold on a plan
$549.54K 37,358 at 14.71
3.1%
Planned (10b5-1)
3 Feb 2026
Staley Gary W SVP Global Sales NSE
Sold at will
$537.63K 20,742 at 25.92
10.2%
Not planned
3 Feb 2026
ROTE WILLIAM E. Chief Research Officer
Sold on a plan
$409.10K 12,446 at 32.87
10.2%
Planned (10b5-1)
3 Feb 2026
Kellermann Kimberly Anne SVP, Chief Operations Officer
Sold at will
$379.03K 5,265 at 71.99
47.5%
Not planned
3 Feb 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$378.23K 1,639 at 230.77
1.2%
Planned (10b5-1)
3 Feb 2026
Williams James P SVP-CHRO
Sold at will
$352.17K 5,243 at 67.17
9.7%
Not planned
3 Feb 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$307.84K 1,334 at 230.77
0.6%
Planned (10b5-1)
3 Feb 2026
Capel Mary Clara Retired Board Member
Sold at will
$296.55K 5,000 at 59.31
19.7%
Not planned
3 Feb 2026
Chaney Brian K Senior Vice President
Sold at will
$288.04K 11,157 at 25.82
11.2%
Not planned
3 Feb 2026
Procacci Riccardo Senior Vice President
Sold at will
$248.09K 800 at 310.11
4.8%
Not planned
3 Feb 2026
Heerma Peter CHIEF COMMERCIAL OFFICER
Sold at will
$234.80K 7,310 at 32.12
5.3%
Not planned
3 Feb 2026
REED ELIZABETH E Chief Legal Officer and GC
Sold at will
$230.46K 7,175 at 32.12
6.2%
Not planned
3 Feb 2026
Crystal Adam President, R&D
Sold at will 2×
$226.30K 18,452 at 12.26
9.0%
Not planned
3 Feb 2026
Inrig Jula CHIEF MEDICAL OFFICER
Sold at will
$223.43K 6,956 at 32.12
6.1%
Not planned
3 Feb 2026
Sathyanarayanan Bala EVP, Chief Human Resources Off
Sold at will
$180.65K 2,499 at 72.29
5.0%
Not planned
3 Feb 2026
Singh Ritadhwaja Jebens EVP & CHIEF DIGITAL OFFICER
Sold on a plan
$178.22K 5,880 at 30.31
5.4%
Planned (10b5-1)
3 Feb 2026
Richards Jay D. Officer of Subsidiary
Sold at will
$174.70K 3,506 at 49.83
8.9%
Not planned
3 Feb 2026
ROBINS HARLAN S Chief Scientific Officer
Sold on a plan
$154.28K 8,120 at 19.00
0.7%
Planned (10b5-1)
3 Feb 2026
Rieger April Chief Lgl. & Admin Ofc., Sec
Sold at will
$150.91K 8,078 at 18.68
3.5%
Not planned
3 Feb 2026
FISHER ERIKA ASHLEY Chief Legal Officer
Sold on a plan
$148.36K 589 at 251.88
5.1%
Planned (10b5-1)
3 Feb 2026
Smith Jason Drew General Counsel
Sold at will 3×
$147.26K 7,479 at 19.69
12.7%
Not planned
3 Feb 2026
Schoenberg Mark Chief Medical Officer
Sold at will 3×
$145.17K 7,373 at 19.69
4.8%
Not planned
3 Feb 2026
Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER
Sold at will
$139.18K 4,333 at 32.12
8.1%
Not planned
3 Feb 2026
MAETZOLD DEREK J Pres. & Chief Exec. Officer
Sold on a plan
$127.72K 3,200 at 39.91
3.6%
Planned (10b5-1)
3 Feb 2026
Finn Patrick John President and COO
Sold at will
$125.99K 2,705 at 46.58
0.9%
Not planned
3 Feb 2026
Indelicarto Thomas C EVP, Gen Counsel & Secretary
Sold on a plan 2×
$124.04K 498 at 249.08
1.6%
Planned (10b5-1)
3 Feb 2026
Flammer Martina M.D. Chief Medical Officer
Sold on a plan
$123.84K 795 at 155.77
0.9%
Planned (10b5-1)
3 Feb 2026
Adsett Roger Chief Operating Officer
Sold at will
$123.53K 791 at 156.17
0.7%
Not planned
3 Feb 2026
Roller David L. Senior Vice President
Sold at will
$111.55K 2,092 at 53.32
6.7%
Not planned
3 Feb 2026
Foehr David Senior VP, Finance and PAO
Sold on a plan 2×
$111.12K 5,556 at 20.00
22.7%
Planned (10b5-1)
3 Feb 2026
Sold on a plan 2×
$109.90K 10,000 at 10.99
0.5%
Planned (10b5-1)
Showing 17,301–17,350 of 22,707. ← Newer Page 347 of 455 Older →